HK1002123A1 - Recombinant human endothelial cell growth factor - Google Patents
Recombinant human endothelial cell growth factorInfo
- Publication number
- HK1002123A1 HK1002123A1 HK98101233A HK98101233A HK1002123A1 HK 1002123 A1 HK1002123 A1 HK 1002123A1 HK 98101233 A HK98101233 A HK 98101233A HK 98101233 A HK98101233 A HK 98101233A HK 1002123 A1 HK1002123 A1 HK 1002123A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- endothelial cell
- growth factor
- cell growth
- recombinant human
- human endothelial
- Prior art date
Links
- 101000846416 Homo sapiens Fibroblast growth factor 1 Proteins 0.000 title 1
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 abstract 3
- 102100031706 Fibroblast growth factor 1 Human genes 0.000 abstract 3
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 210000004204 blood vessel Anatomy 0.000 abstract 1
- 238000010367 cloning Methods 0.000 abstract 1
- 230000003511 endothelial effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C07K14/501—Fibroblast growth factor [FGF] acidic FGF [aFGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/835,594 US4868113A (en) | 1986-03-03 | 1986-03-03 | Recombinant DNA vector encoding human endothelial cell growth factor |
PCT/US1987/000425 WO1987005332A1 (en) | 1986-03-03 | 1987-03-02 | Recombinant human endothelial cell growth factor |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1002123A1 true HK1002123A1 (en) | 1998-07-31 |
Family
ID=25269917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98101233A HK1002123A1 (en) | 1986-03-03 | 1998-02-17 | Recombinant human endothelial cell growth factor |
Country Status (16)
Country | Link |
---|---|
US (1) | US4868113A (de) |
EP (1) | EP0259475B1 (de) |
JP (4) | JPS63502725A (de) |
KR (1) | KR960002874B1 (de) |
AT (1) | ATE110782T1 (de) |
AU (1) | AU617086B2 (de) |
DE (1) | DE3750451T2 (de) |
DK (1) | DK175807B1 (de) |
FI (1) | FI874819A (de) |
HK (1) | HK1002123A1 (de) |
IE (1) | IE66307B1 (de) |
NZ (1) | NZ219485A (de) |
PH (1) | PH24857A (de) |
RU (1) | RU1804480C (de) |
UA (1) | UA13321A (de) |
WO (1) | WO1987005332A1 (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5401832A (en) * | 1984-12-24 | 1995-03-28 | Merck & Co., Inc. | Brain derived and recombinant acidic fibroblast growth factor |
WO1989000198A1 (en) * | 1987-07-07 | 1989-01-12 | Biotechnology Research Associates, J.V. | Recombinant fibroblast growth factors |
EP0593065B1 (de) * | 1985-09-12 | 2002-08-21 | Scios Inc. | Rekombinante Fibroblasten-Wachstums-Faktoren |
US5552528A (en) * | 1986-03-03 | 1996-09-03 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Bovine b-endothelial cell growth factor |
US5827826A (en) | 1986-03-03 | 1998-10-27 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Compositions of human endothelial cell growth factor |
NZ220917A (en) * | 1986-07-11 | 1991-05-28 | Merck & Co Inc | Human and bovine acidic fibroblast growth factor vectors, hosts and compositions |
NZ226543A (en) * | 1987-10-22 | 1992-02-25 | Merck & Co Inc | Recombinant mutant acidic fibroblast growth factor |
US5312911A (en) * | 1987-10-22 | 1994-05-17 | Merck & Co., Inc. | Cysteine-modified acidic fibroblast growth factor |
US5258287A (en) * | 1988-03-22 | 1993-11-02 | Genentech, Inc. | DNA encoding and methods of production of insulin-like growth factor binding protein BP53 |
GB2223497B (en) * | 1988-08-08 | 1992-04-01 | British Bio Technology | Synthetic gene encoding human beta endothelial cell growth factor |
GB2223496B (en) * | 1988-08-08 | 1992-05-27 | British Bio Technology | Synthetic gene encoding mature human acid fibroblast growth factor |
US5656458A (en) * | 1988-11-04 | 1997-08-12 | Chiron Corporation | Expression and processing of amino terminus acetylated FGF's in yeast |
ATE141643T1 (de) * | 1988-11-04 | 1996-09-15 | Chiron Corp | Expression und prozessierung von acetylierten fgfs in hefen |
US5227302A (en) * | 1988-12-20 | 1993-07-13 | Ludwig Institute For Cancer Research | DNA encoding platelet derived endothelial cell growth factor (PD-ECGF) |
US5756686A (en) * | 1988-12-20 | 1998-05-26 | Ludwig Institute For Cancer Research | Peptides derived from endothelial cell growth factor |
HU218090B (hu) | 1989-01-31 | 2000-05-28 | Stuart A. Aaronson | Eljárás hámsejtekre specifikus növekedési faktor és az ezt kódoló DNS, az ez ellen termelődött antitestek valamint a növekedési faktort vagy az antitestet tartalmazó gyógyászati készítmények előállítására |
US7026291B1 (en) | 1989-01-31 | 2006-04-11 | The United States Of America As Represented By The Department Of Health And Human Services | Epithelial cell specific growth factor, keratinocyte growth factor (KGF) |
US5595887A (en) * | 1990-07-16 | 1997-01-21 | Bionebraska, Inc. | Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment |
US5244460A (en) * | 1991-11-27 | 1993-09-14 | The United States Of America As Represented By The Department Of Health And Human Services | Method to foster myocardial blood vessel growth and improve blood flow to the heart |
US5348941A (en) * | 1992-04-01 | 1994-09-20 | Merck & Co., Inc. | Stabilizers for fibroblast growth factors |
US5656598A (en) * | 1994-03-08 | 1997-08-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Use of fibroblast growth factors to stimulate bone growth |
CA2184916C (en) * | 1994-03-08 | 2008-05-13 | Colin R. Dunstan | Use of fibroblast growth factors to stimulate bone growth |
US5817485A (en) * | 1994-03-08 | 1998-10-06 | Human Genome Sciences, Inc. | Nucleic acids and cells for recombinant production of fibroblast growth factor-10 |
US20050019824A1 (en) * | 1994-03-08 | 2005-01-27 | Human Genome Sciences, Inc. | Fibroblast Growth Factor-10 |
US6551618B2 (en) | 1994-03-15 | 2003-04-22 | University Of Birmingham | Compositions and methods for delivery of agents for neuronal regeneration and survival |
AU712297B2 (en) * | 1995-06-05 | 1999-11-04 | Human Genome Sciences, Inc. | Fibroblast growth factor 11 |
US6110893A (en) * | 1995-06-05 | 2000-08-29 | Human Genome Sciences, Inc. | Fibroblast growth factor 11 |
US6605441B1 (en) * | 1995-06-05 | 2003-08-12 | Human Genome Sciences, Inc. | Antibodies against fibroblast growth factor 11 |
WO1996041818A1 (en) * | 1995-06-09 | 1996-12-27 | Drohan William N | Chitin hydrogels, methods of their production and use |
US5876730A (en) * | 1997-08-07 | 1999-03-02 | Childrens Hospital Research Foundation | Heparin-binding growth factor (HBGF) polypeptides |
US6645947B1 (en) | 1999-05-20 | 2003-11-11 | Chitogenics, Inc. | Adhesive N, O-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins |
US6719805B1 (en) * | 1999-06-09 | 2004-04-13 | C. R. Bard, Inc. | Devices and methods for treating tissue |
WO2002034285A2 (en) | 2000-10-20 | 2002-05-02 | Coolidge Thomas R | Treatment of hibernating myocardium and diabetic cardiomyopathy with a glp-1 peptide |
US6982170B1 (en) | 2001-12-17 | 2006-01-03 | Maine Medical Center Research Institute | Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1 |
US7265097B2 (en) * | 2002-08-20 | 2007-09-04 | Chitogenics, Inc. | Methods of drug delivery using sulphated chitinous polymers |
ATE513823T1 (de) * | 2004-08-17 | 2011-07-15 | Simpson Biotech Co Ltd | Mischung und verbindungen von mycelien von antrodia camphorata und deren verwendung |
US8357146B2 (en) * | 2005-05-18 | 2013-01-22 | Cooltouch Incorporated | Treatment of cellulite and adipose tissue with mid-infrared radiation |
US8256429B2 (en) * | 2005-05-18 | 2012-09-04 | Cooltouch Incorporated | Treatment of cellulite and adipose tissue with mid-infrared radiation |
US8276590B2 (en) | 2005-05-18 | 2012-10-02 | Cooltouch Incorporated | Thermally mediated tissue molding |
US20070134204A1 (en) * | 2005-12-09 | 2007-06-14 | Henrich Cheng | Method for treating nerve injury and vector construct for the same |
JP2011121882A (ja) * | 2009-12-09 | 2011-06-23 | Eu Sol Biotech Co Ltd | ヒト酸性繊維芽細胞増殖因子の改変ペプチド |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0593065B1 (de) * | 1985-09-12 | 2002-08-21 | Scios Inc. | Rekombinante Fibroblasten-Wachstums-Faktoren |
-
1986
- 1986-03-03 US US06/835,594 patent/US4868113A/en not_active Expired - Lifetime
-
1987
- 1987-03-02 EP EP87902208A patent/EP0259475B1/de not_active Expired - Lifetime
- 1987-03-02 WO PCT/US1987/000425 patent/WO1987005332A1/en active IP Right Grant
- 1987-03-02 AT AT87902208T patent/ATE110782T1/de not_active IP Right Cessation
- 1987-03-02 AU AU72012/87A patent/AU617086B2/en not_active Expired
- 1987-03-02 UA UA4203874A patent/UA13321A/uk unknown
- 1987-03-02 JP JP62502073A patent/JPS63502725A/ja active Pending
- 1987-03-02 KR KR1019870701012A patent/KR960002874B1/ko not_active IP Right Cessation
- 1987-03-02 DE DE3750451T patent/DE3750451T2/de not_active Expired - Lifetime
- 1987-03-03 NZ NZ219485A patent/NZ219485A/xx unknown
- 1987-03-03 PH PH34950A patent/PH24857A/en unknown
- 1987-03-03 IE IE53587A patent/IE66307B1/en not_active IP Right Cessation
- 1987-11-02 RU SU874203874A patent/RU1804480C/ru active
- 1987-11-02 DK DK198705724A patent/DK175807B1/da not_active IP Right Cessation
- 1987-11-02 FI FI874819A patent/FI874819A/fi not_active IP Right Cessation
-
1995
- 1995-12-12 JP JP34940895A patent/JP3273354B2/ja not_active Expired - Lifetime
-
1996
- 1996-07-08 JP JP8177653A patent/JPH09294590A/ja active Pending
-
1997
- 1997-12-03 JP JP33251897A patent/JP3372464B2/ja not_active Expired - Lifetime
-
1998
- 1998-02-17 HK HK98101233A patent/HK1002123A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0259475B1 (de) | 1994-08-31 |
DE3750451T2 (de) | 1994-12-22 |
AU617086B2 (en) | 1991-11-21 |
JPH10175999A (ja) | 1998-06-30 |
IE870535L (en) | 1987-09-03 |
RU1804480C (ru) | 1993-03-23 |
JPH09135690A (ja) | 1997-05-27 |
UA13321A (uk) | 1997-02-28 |
FI874819A0 (fi) | 1987-11-02 |
JPH09294590A (ja) | 1997-11-18 |
EP0259475A4 (de) | 1989-10-12 |
JP3372464B2 (ja) | 2003-02-04 |
EP0259475A1 (de) | 1988-03-16 |
DK572487A (da) | 1987-11-02 |
NZ219485A (en) | 1990-02-26 |
DK572487D0 (da) | 1987-11-02 |
DE3750451D1 (de) | 1994-10-06 |
DK175807B1 (da) | 2005-03-07 |
KR880700858A (ko) | 1988-04-12 |
US4868113A (en) | 1989-09-19 |
IE66307B1 (en) | 1995-12-27 |
KR960002874B1 (ko) | 1996-02-27 |
PH24857A (en) | 1990-12-26 |
WO1987005332A1 (en) | 1987-09-11 |
ATE110782T1 (de) | 1994-09-15 |
JPS63502725A (ja) | 1988-10-13 |
FI874819A (fi) | 1987-11-02 |
JP3273354B2 (ja) | 2002-04-08 |
AU7201287A (en) | 1987-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH24857A (en) | Recombinant human endothelial cell growth factor | |
ATE294864T1 (de) | Äusseres membranprotein von haemophilus | |
GR3004903T3 (de) | ||
DE3684892D1 (de) | Eukaryotische fusionsproteine, ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens. | |
WO1994003620A3 (en) | Method of increasing expression of viral proteins | |
ATE71632T1 (de) | Cdns und gen fuer menschliches angiogenin (angiogenesis-faktor) und expression. | |
WO2000034474A3 (en) | Growth factor homolog zvegf3 | |
KR900002795A (ko) | 하이브리드 단백질c 작제물 및 그들의 제조방법 | |
IE871871L (en) | Cloning and expression of acidic fibroblast growth factor | |
AU8209187A (en) | Hybrid proteins | |
HK1007333A1 (en) | Variants of plasminogen activatos and processes for their production | |
DE3881023D1 (de) | Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten. | |
ES8802441A1 (es) | Procedimiento para preparar laminina humana | |
HUP9901161A2 (hu) | Módosított aktivitású hibrid VIII. faktor | |
AU650649B2 (en) | Human placenta angiogenic factor capable of stimulating capillary endothelial cell protease synthesis, DNA synthesis and migration | |
ES8605296A1 (es) | Procedimiento de producir factor viii-r humano | |
HUP0001057A2 (hu) | A szarvasmarhafélék laktációjával összefüggő fehérje (CD14), az azt kódoló gén és a fehérje B-sejt-aktiválásban való alkalmazása | |
AU1948788A (en) | Expression of immunologically active proteins of human b-lymphotropic virus | |
TH4656EX (th) | รีคอมบิแนนท์ เอนโดเธเลียล เซลล์โกรว์ธ แฟกเตอร์ของมนุษย์ | |
TH4656A (th) | รีคอมบิแนนท์ เอนโดเธเลียล เซลล์โกรว์ธ แฟกเตอร์ของมนุษย์ | |
UA5743C2 (uk) | Препарат тканинних біологічно активних речовин, який має регенаторну дію, та спосіб його одержання | |
PT85226A (en) | Process for the preparation of novel trombolytic proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PE | Patent expired |
Effective date: 20070301 |